
ProPharma Announces the Appointment of Dr. Ronald Freeze, Ph.D., as Global Head of Medical Technology
RALEIGH, NC, May 17, 2023, ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of Odyssey...

ProPharma Announces Strategic Partnership with H1 to Optimize R&D with AI, Data Insights and Analytics
RALEIGH, NC, May 9, 2023, ProPharma Group (ProPharma), the world’s largest Research Consulting Organization (RCO) and a portfolio company of Odyssey Investment Partners, and H1, a leading healthcare...

ProPharma Announces New Global Headquarters in Raleigh, NC as Hub for Innovation and Talent
RALEIGH, NC, April 3, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry and a portfolio company of Odyssey...

ProPharma Group Announces Acquisition of Kateric, An Industry-Leading Medical Writing Company
Chicago, IL, September 1, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical and quality services for the life sciences industry, announces the acquisition of Kateric...

ProPharma Group Acquires OneSource Regulatory to Bolster its Regulatory Consultancy Services
Chicago, IL, August 23, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical, quality and compliance, medical information, and pharmacovigilance services and solutions...

Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials
DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...

